LONDON, June 24, 2025 /PRNewswire/ -- Enfuse Group, a leading digital transformation consultancy and certified B Corp, is delighted to announce a strategic investment from Agathos Management LLP, a UK ...
CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufacturing the enFuse® on-body drug delivery system, announced today ...
The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...
LONDON, Nov. 19, 2024 /PRNewswire/ -- Enfuse Group are on a mission to prove that being a high performing consultancy doesn't have to mean compromising on social and environmental responsibility. As ...
CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), today ...
Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse® system designed to enhance the patient experience and support adherence-related ...
An on-body delivery system approved last fall for paroxysmal nocturnal hemoglobinuria (PNH) has seen rapid uptake and is now being studied for use with isatuximab. Improving cancer care isn’t just ...
Enfuse Solutions IPO allotment: The allotment for Enfuse Solutions IPO will be finalised on March 20. Investors who have applied for the issue can check their allotment status on the website of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results